Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol.

Carolina B MacielFernanda J P TeixeiraKatie J DickinsonJessica C SpanaLisa H MerckAlejandro A RabinsteinRobert SergottGuogen ShanGuanhong MiaoCharles A PeloquinKatharina M BuslLawrence J Hirsch

Published in: Neurological research and practice (2022)

Vigabatrin demonstrates high potential for synergism with current standard of care therapies. Demonstration of the feasibility of vigabatrin administration and preliminary safety in PASE will pave the way for future efficacy and safety trials of this pharmacotherapeutic. Trial Registration NCT04772547.

Keyphrases

study protocol
clinical trial
randomized controlled trial
phase ii
phase iii
open label
healthcare
double blind
palliative care
quality improvement
cell proliferation
current status
placebo controlled
pain management
climate change